Assessment of Clinical Examination Validity in Oral Cancer Risk Patients

Summary Background/Aim: Oral cancer is one of the ten most common cancers in the world, recently positioned as a sixth one, unfortunately with poor prognosis after treatment because of the late diagnostics in advanced stages of the disease. Aim of this study was to present the basic criteria in assessment the accuracy/efficacy, specificity and sensitivity, the positive and negative predicted values of the conventional oral examination (COE) as the easiest and most acceptable procedure in detection of the early changes of the suspicious oral tissue changes compared to the diagnostic gold standard – tissue biopsy in two different groups of examinees. Material and Methods: Sixty patients divided into two study groups (one with potentially malignant oral lesions and a second consisted of clinically suspicious oral cancer lesions) were examined with COE and subjected to histopathological confirmation - tissue biopsy. All examined patients underwent the diagnostic protocol by the American Joint Commission on Cancer, selected under certain inclusion and exclusion criteria. Results: Sensitivity of COE in the group of examinees with oral potentially malignant lesions is 83.33%, its specificity is 20.83%, the positive predictive value is 20.83% and the negative predictive value is 83.33%. The accuracy of the COE method is 33.33%. The sensitivity, in the group of patients with oral cancer is 96.43%, specificity is 0%, the positive predictive value is 93.10% and the negative predictive value is 0%. The accuracy of this method is 90%. Conclusions: The accuracy reaches a value over 90% for the group with lesions with highly suspected malignant potential – oral cancer, and sets the thesis that COE as screening method for oral cancer or premalignant tissue changes is more valuable for the patients with advanced oral epithelial changes, but is recommended to be combined with some other type of screening procedure in order to gain relevant results applicable in the everyday clinical practice.

[1]  S. A. Haider,et al.  Genetic etiology of oral cancer. , 2017, Oral oncology.

[2]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[3]  Chung-Ji Liu,et al.  SMAD4 Somatic Mutations in Head and Neck Carcinoma Are Associated With Tumor Progression , 2019, Front. Oncol..

[4]  Crispian Scully,et al.  Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. , 2013, The Cochrane database of systematic reviews.

[5]  P. Poitras.  [THE CANADIAN DENTAL ASSOCIATION]. , 1965, Journal of the Canadian Dental Association.

[6]  N D Le,et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  A. Ramanathan,et al.  Mouth self-examination as a screening tool for oral potentially malignant disorders among a high-risk Indigenous population. , 2019, Journal of public health dentistry.

[8]  L. Alós,et al.  Oral premalignant lesions of smokers and non-smokers show similar carcinogenic pathways and outcomes. A clinicopathological and molecular comparative analysis. , 2019, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  S C Shiboski,et al.  Trends in oral cancer rates in the United States, 1973-1996. , 2000, Community dentistry and oral epidemiology.

[10]  H Hillenbrand.  American Dental Association. , 1959, Journal of the American Dental Society of Anesthesiology.

[11]  L J Schouten,et al.  False-negative findings in skin cancer and melanoma screening. , 1995, Journal of the American Academy of Dermatology.

[12]  R. Melrose.  Premalignant oral mucosal diseases. , 2001, Journal of the California Dental Association.

[13]  Stephen Palmer,et al.  A systematic review of test performance in screening for oral cancer and precancer. , 2004, Oral oncology.

[14]  S. Silverman,et al.  Oral Leukoplakia and Malignant Transformation , 2006 .

[15]  P. Vescovi,et al.  Non-invasive visual tools for diagnosis of oral cancer and dysplasia: A systematic review , 2016, Medicina oral, patologia oral y cirugia bucal.

[16]  A. K. Mascarenhas,et al.  Utility of oral cancer diagnostic adjuncts in the adult US populations. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  J. Whited,et al.  The rational clinical examination. Does this patient have a mole or a melanoma? , 1998, JAMA.

[18]  M. Gorsky,et al.  Oral leukoplakia and malignant transformation. A follow‐up study of 257 patients , 1984, Cancer.

[19]  Y. Wong,et al.  Visual screening of oral cavity cancer in a male population: Experience from a medical center , 2011, Journal of the Chinese Medical Association : JCMA.

[20]  J. Pindborg,et al.  Reliability of oral precancer screening by primary health care workers in Sri Lanka. , 1990, Community dental health.

[21]  Melrose Rj.  Premalignant oral mucosal diseases. , 2001 .

[22]  P. Thomson.  Field change and oral cancer: new evidence for widespread carcinogenesis? , 2002, International journal of oral and maxillofacial surgery.

[23]  J. Epstein,et al.  Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: role of primary care physicians. , 2008, Canadian family physician Medecin de famille canadien.

[24]  R. Burbano,et al.  PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma , 2018, Histopathology.

[25]  M. Downer,et al.  Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. , 1995, Community dental health.

[26]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[27]  Elliot Abt,et al.  The limitations of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma. , 2012, Texas dental journal.

[28]  S Silverman,et al.  Early diagnosis of oral cancer , 1988, Cancer.

[29]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[30]  P. Chaturvedi,et al.  Oral cancer: Premalignant conditions and screening--an update. , 2012, Journal of cancer research and therapeutics.

[31]  P. Pisani,et al.  Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. , 1997, British Journal of Cancer.

[32]  L. Patton,et al.  Detecting, diagnosing, and preventing oral cancer. , 1997, The Nurse practitioner.

[33]  G. Ogden,et al.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. , 2015, The Cochrane database of systematic reviews.

[34]  Y. Teerawattananon,et al.  Cost-utility analysis of the screening program for early oral cancer detection in Thailand , 2018, PloS one.

[35]  M. Downer,et al.  Characteristics of participants and non-participants in annual mass screening for oral cancer in 60-year-old residents of Tokoname city, Japan. , 1995, Community dental health.